ProShares Metaverse ETF VERS 深 滬
等待開盤 10-03 09:30:00 美东时间
62.2333
+0.885
+1.44%
華盛通- 最 高62.2333
- 今 開62.14
- 成交量 123股
- 最 低 62.14
- 昨 收 61.3488
- 總市值 684.57万
- 52周最高 62.5337
- 市盈率 靜 --
- 換手率 0.11%
- 52周最低 38.7944
- 委 比 0.00%
- 總股本 11.00万
- 歷史最高 62.5337
- 量 比 0
- 振 幅 0.15%
- 歷史最低 26.1805
- 每 手 1
- 風險率 5.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Beer, Lesbians and Baseball! Casting Announced for New Crave Original Comedy Series, SLO PITCH
– The series stars Jess Salgueiro, Karen Knox, Gwenlyn Cumyn, Emma Hunter, and Emily Hampshire, with special guest star, women's softball legend Ayami Sato – – Shooting now in Toronto, Hami...
10-02 23:55
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
VIZZ sample distribution initiated nationwide to Eye Care Professionals Commercial product shipments to be initiated in October to consumers with broad product availability by mid-Q4 2025 VI...
09-30 20:05
PDS Biotechnology Announces VERSATILE-002 Trial Success
The latest announcement is out from PDS Biotechnology ( ($PDSB) ). On September...
09-18 21:19
PDS Biotech Reports 29.5-Month Median Overall Survival In Phase 2 Trial For Advanced Head And Neck Cancer; Says Encouraging Efficacy Signal Observed In Difficult To Treat Category Of Advanced Head And Neck Cancer Patients
First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months) and Keytruda® + chemotherapy (12.3 months) in patients with CPS
09-18 20:47
Nutriband Reports 50.87% Revenue Growth, $6.9M Cash; Advances AVERSA Fentanyl Toward NDA With No Phase 2/3 Trials Required
Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the six months ended July 31, 2025. The company reported a strong cash position at quarter end, reinforcing its ability to advance the
09-10 21:20
小摩：泡泡玛特旗下Mini版Labubu及星星人热度续升 维持“增持”评级
摩根大通发布研报称，从泡泡玛特（09992）双周品牌热度分析显示，随着“Labubu与朋友”动画及Labubu4.0版本推出，未来搜寻热度料将回升；6月起...
09-10 15:29
VERSABANK DECLARES DIVIDENDS
LONDON, ON, Sept. 4, 2025 /PRNewswire/ - VersaBank (the "Bank") (TSX: VBNK; NASDAQ: VBNK) today announced that cash dividends in the amount of CAD $0.025 per Common Share of the Bank have be...
09-04 19:00
American Regent® Launches Gvoke VialDx™ (glucagon injection)
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commerc...
08-27 20:35
Hagerty Introduces Complimentary Severe Weather Storage Service for Florida Members
Hagerty Safe Storage Concierge provides parking garage storage for classic and enthusiast vehicles TRAVERSE CITY, Mich., Aug. 26, 2025 /PRNewswire/ -- Hagerty members love their classic and ...
08-27 02:30
PDS Biotechnology Reports Median Overall Survival Of 39.3 Months In HPV16-Positive Head And Neck Cancer Patients
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months*VERSATILE-003 Phase 3 trial in
08-25 20:34
